Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

9.63
Delayed Data
As of 2:16pm ET
 +0.62 / +6.88%
Today’s Change
3.96
Today|||52-Week Range
9.68
+98.15%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close9.01
Today’s open9.02
Day’s range9.02 - 9.68
Volume32,834
Average volume (3 months)17,692
Market cap$27.3M
Dividend yield--
Data as of 2:16pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)-250.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+26.46%
P/E ratio90.5
Price/Sales1.94
Price/Book2.95

Competitors

 Today’s
change
Today’s
% change
--Cell Source Inc0.000.00%
RXIIRxi Pharmaceuticals ...-0.01-2.24%
ENUMEnumeral Biomedical ...0.000.00%
ENZBEnzymeBioSystems-0.06-3.14%
Data as of 2:17pm ET, 07/29/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$7.6M
Annual profit (last year)-$167.2K
Net profit margin-2.20%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, CFO, Secretary &
Treasurer
Michael F. Brigham
Director, Chief Scientific Officer &
VP
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts